WHAT'S HAPPENING IN MY REGION?

Selected region : west
Date: : 28th Jun 2019

For All Current Studies ongoing in the West click HERE.

SHARE Studies

CORONAGENES
Researchers at the University of Edinburgh aim to understand the genetic susceptibility to coronavirus infection. They will also examine the genetic influences on the severity and outcomes of coronavirus, particularly for less severe cases. The focus will not just be individuals who are admitted to hospital and critical care.

They are looking for both participants who are suffered from COVID-19 and those who have not. People who have not contracted the disease or had symptoms are just as important to the study as people who have.

For more information about this study please click here.


ELVIS-COVID

The University of Edinburgh are running a study called ELVIS COVID-19 to find out if nasal washout and gargling with salt water helps individuals with COVID-19 get better faster by helping to ease the symptoms of the virus.

If you have developed symptoms of COVID-19 including a continuous cough or high temperature or loss of sense of smell or taste within the past 48 hours, the study team would appreciate your help with this study.

For more information about this study please click here.

 

Other studies ongoing in the West of Scotland

For All Current Studies ongoing in the West click HERE.

 

Pulmonary Hemodynamics During Exercise - Research Network

The purpose of this Clinical Research Collaboration is to investigate the prognostic implications of pulmonary hemodynamics during exercise based on a large scale multi-centre approach by using retrospective and prospective analysis of hemodynamic data.

A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutamide from the subjects participation in an enzalutamide clinical study sponsored by Astellas or Medivation (i.e., parent study) which has completed, at a minimum, the primary analysis or the study specified evaluation period.

A Study of ASP1948, Targeting an Immune Modulatory Receptor as a Single Agent and in Combination With a PD-l Inhibitor (Nivolumab or Pembrolizumab) in Subjects With Advanced Solid Tumours

The purpose of this study is to evaluate the tolerability and safety profile of ASP1948 when administered as a single agent and in combination with nivolumab or pembrolizumab in participants with locally advanced (unresectable) or metastatic solid tumors; characterize the pharmacokinetic profile of ASP1948 when administered as a single agent and in combination with nivolumab or pembrolizumab and determine the recommended Phase 2 dose (RP2D) of ASP1948 when administered as a single agent and in combination with nivolumab or pembrolizumab.

Online group and peer support speech therapy for people with progressive ataxia

Ataxia is a term for a group of disorders that affect co-ordination, balance and speech. People with progressive ataxia often suffer from communication difficulties.

Evaluation of the Long Term Safety, Tolerability and Efficacy of Two Dosing Regimens of Olokizumab (OKZ), in Subjects With Rheumatoid Arthritis (RA) Who Previously Completed 24 Weeks of Blinded Treatment in One of the Core Studies - CREDO 1, 2 or 3.

The purpose of the study is to evaluate how safe, how effective and how well tolerated, the study drug Olokizumab is, in the long-term, in patients with Rheumatoid Arthritis (RA) who have previously taken part in and completed 24 weeks of blinded treatment in one of the core studies - CREDO 1, 2 or 3.

PROFILE - personalised medicine in Crohn's disease

Crohn’s disease is a type of inflammatory bowel disease (IBD) that can affect any part of the intestine. The severity of Crohn’s disease varies a lot between different people, and this means that what might be the best treatment for one person may not be appropriate for someone else. This study will see whether a simple blood test (‘biomarker’) can improve Crohn’s disease outcomes and reduce the number of flares experienced by enabling delivery of ‘personalised therapy’ (that is, treatment tailored to the individual person based on their predicted disease course and severity).

Lowering Events in Non-proliferative retinopathy in Scotland

The aim of this study is to evaluate if fenofibrate therapy will slow the progression of diabetic retinopathy.

Comparing treatments for diabetic foot ulcers T

he aim of this study is to find out the best combination of treatments to use to help DFUs heal more quickly by measuring the size of the ulcer and comparing the healing to the different treatment options.

Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

The primary objective of Enroll-HD is to develop a comprehensive repository of prospective and systematically collected clinical research data (demography, clinical features, family history, genetic characteristics) and biological specimens (blood) from individuals with manifest HD, unaffected individuals known to carry the HD mutation or at risk of carrying the HD mutation, and control research participants (e.g., spouses, siblings or offspring of HD mutation carriers known not to carry the HD mutation).

A Study to Assess How Well Certolizumab Pegol Works in Patients With Moderate to Severe Plaque Psoriasis as Part of Routine Clinical Practice

A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis

This study will evaluate the efficacy and safety of ocrelizumab ( Ocrevus®) compared with placebo in participants with primary progressive multiple sclerosis (PPMS), including participants later in their disease course. This study focuses on upper limit disability progression.

Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours

Add-Aspirin aims to assess whether regular aspirin use after standard curative therapy can prevent recurrence and improve survival in individuals with non-metastatic common tumours.